The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
13 01 2023
Historique:
received: 16 12 2022
revised: 09 01 2023
accepted: 11 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

Connective tissue growth factor (CTGF) is involved in the regulation of extracellular matrix (ECM) production. Elevated levels of CTGF can be found in plasma from patients with liver fibrosis and in experimental animal models of liver fibrosis, but the exact role of CTGF in, e.g., diet-induced human liver fibrosis is not entirely known. To address this question, we utilized a 3D human liver co-culture spheroid model composed of hepatocytes and non-parenchymal cells, in which fibrosis is induced by TGF-β1, CTGF or free fatty acids (FFA). Treatment of the spheroids with TGF-β1 or FFA increased COL1A1 deposition as well as the expression of TGF-β1 and CTGF. Recombinant CTGF, as well as angiotensin II, caused increased expression and/or production of CTGF, TGF-β1, COL1A1, LOX, and IL-6. In addition, silencing of CTGF reduced both TGF-β1- and FFA-induced COL1A1 deposition. Furthermore, we found that IL-6 induced CTGF, COL1A1 and TGF-β1 production, suggesting that IL-6 is a mediator in the pathway of CTGF-induced fibrosis. Taken together, our data indicate a specific role for CTGF and CTGF downstream signaling pathways for the development of liver inflammation and fibrosis in the human 3D liver spheroid model.

Identifiants

pubmed: 36672237
pii: cells12020302
doi: 10.3390/cells12020302
pmc: PMC9857203
pii:
doi:

Substances chimiques

Connective Tissue Growth Factor 139568-91-5
Interleukin-6 0
Transforming Growth Factor beta1 0
CCN2 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Front Immunol. 2022 Aug 25;13:983255
pubmed: 36091042
Biomedicines. 2020 Sep 04;8(9):
pubmed: 32899801
Front Cell Dev Biol. 2020 Oct 29;8:593269
pubmed: 33195264
Exp Eye Res. 2009 Jun;88(6):1065-75
pubmed: 19450452
J Hepatol. 2000 May;32(5):754-61
pubmed: 10845662
Cells. 2020 Feb 06;9(2):
pubmed: 32041253
Arch Biochem Biophys. 2020 Aug 15;689:108445
pubmed: 32524998
Matrix Biol. 2018 Aug;68-69:44-66
pubmed: 29574063
Comp Hepatol. 2007 May 02;6:5
pubmed: 17474984
Cells. 2019 Nov 11;8(11):
pubmed: 31718044
Hormones (Athens). 2022 Mar;21(1):41-49
pubmed: 34854066
J Hepatol. 2019 Mar;70(3):531-544
pubmed: 30414863
Hum Vaccin Immunother. 2020 Oct 2;16(10):2357-2362
pubmed: 32530750
Fibrogenesis Tissue Repair. 2012 Jun 06;5(Suppl 1):S24
pubmed: 23259531
Gene Ther. 2007 May;14(10):790-803
pubmed: 17344905
Basic Clin Pharmacol Toxicol. 2022 Jan;130 Suppl 1:5-15
pubmed: 33872466
Int J Mol Sci. 2016 May 20;17(5):
pubmed: 27213358
Rom J Morphol Embryol. 2011;52(1 Suppl):409-12
pubmed: 21424084
World J Gastroenterol. 2017 Sep 28;23(36):6549-6570
pubmed: 29085205
Sci Rep. 2017 Aug 10;7(1):7841
pubmed: 28798388
Nat Rev Drug Discov. 2020 Jul;19(7):480-494
pubmed: 32555376
J Cell Commun Signal. 2021 Dec;15(4):567-580
pubmed: 34613590
Front Endocrinol (Lausanne). 2020 Nov 26;11:597583
pubmed: 33324348
Cell Mol Life Sci. 2019 Jan;76(1):99-128
pubmed: 30343320
J Cell Physiol. 2022 Jan;237(1):59-85
pubmed: 34286853
Clin Chim Acta. 2014 Jun 10;433:111-22
pubmed: 24607331
Hepatology. 2010 Aug;52(2):774-88
pubmed: 20683968
Sci Rep. 2018 Sep 24;8(1):14297
pubmed: 30250238
Int Immunopharmacol. 2020 Nov;88:106897
pubmed: 32822909
Cells. 2020 Apr 14;9(4):
pubmed: 32295224
Cytokine. 2014 Nov;70(1):11-20
pubmed: 24986424
Liver. 2000 Jul;20(4):296-304
pubmed: 10959808
Hepatol Res. 2003 May;26(1):1-9
pubmed: 12787797
Curr Pharm Des. 2012;18(27):4135-47
pubmed: 22630087
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411
pubmed: 28487545
Tissue Eng Part C Methods. 2018 Sep;24(9):534-545
pubmed: 30101670
Nat Rev Rheumatol. 2019 Dec;15(12):705-730
pubmed: 31712723
Ann Hepatol. 2003 Oct-Dec;2(4):159-63
pubmed: 15115954
Clin Exp Med. 2014 May;14(2):141-50
pubmed: 23456538
Wound Repair Regen. 2004 Jan-Feb;12(1):60-6
pubmed: 14974966
Br J Pharmacol. 2003 Jul;139(6):1085-94
pubmed: 12871826
Cytokine. 2021 Jul;143:155536
pubmed: 33893003
Liver Int. 2008 Sep;28(8):1065-79
pubmed: 18783549
Sci Rep. 2016 May 04;6:25187
pubmed: 27143246
FASEB J. 2017 Jun;31(6):2696-2708
pubmed: 28264975
Front Biosci (Landmark Ed). 2012 Jun 01;17(7):2495-507
pubmed: 22652794
PLoS One. 2012;7(12):e51097
pubmed: 23227240
Hepatology. 1999 Oct;30(4):968-76
pubmed: 10498649
World J Gastroenterol. 2011 Jan 14;17(2):151-63
pubmed: 21245987
Sci Rep. 2020 Dec 3;10(1):21018
pubmed: 33273492
PLoS One. 2014 Apr 24;9(4):e96053
pubmed: 24763697
J Lipid Res. 2017 Mar;58(3):578-585
pubmed: 28082409
PLoS One. 2021 Nov 23;16(11):e0260313
pubmed: 34813621
Cancers (Basel). 2021 Mar 04;13(5):
pubmed: 33806428
Hepatology. 2014 Feb;59(2):483-95
pubmed: 23996730
Gut. 2015 May;64(5):830-41
pubmed: 25681399

Auteurs

Sara Redenšek Trampuž (SR)

Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.

Sander van Riet (S)

Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

Åsa Nordling (Å)

Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

Magnus Ingelman-Sundberg (M)

Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH